Under the spotlight: Amgen’s VP for the Center of Observational Research Will Discuss the Role of RWE in a Comprehensive Product Evidence Generation Plan Read more
Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management Read more
Alexion Pharmaceuticals and Minoryx Therapeutics to Present at SMi’s Orphan Drugs & Rare Diseases Event Read more
Exclusive Interview with Stephen Murby of ASBM Released Ahead of Upcoming Biosimilars Conference Read more